Cart
sales@molnova.com
Simmondsin
CAS No. 51771-52-9
Simmondsin( —— )
Catalog No. M24489 CAS No. 51771-52-9
Simmondsin is a natural product from Simmondsia chinensis -- jojoba. It reduced food intake and body weight without apparent negative effects in rats.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 333 | In Stock |
|
| 10MG | 493 | In Stock |
|
| 25MG | 798 | In Stock |
|
| 50MG | 1098 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSimmondsin
-
NoteResearch use only, not for human use.
-
Brief DescriptionSimmondsin is a natural product from Simmondsia chinensis -- jojoba. It reduced food intake and body weight without apparent negative effects in rats.
-
DescriptionSimmondsin is a natural product from Simmondsia chinensis -- jojoba. It reduced food intake and body weight without apparent negative effects in rats.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number51771-52-9
-
Formula Weight375.37
-
Molecular FormulaC16H25NO9
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCO[C@@H](C[C@H](C([C@@H]1O)=CC#N)O[C@@H]([C@@H]([C@H]2O)O)O[C@H](CO)[C@H]2O)[C@@H]1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Boozer C N , Herron A J . Simmondsin for weight loss in rats[J]. International Journal of Obesity, 2006, 30(7):1143-1148.
molnova catalog
related products
-
Ethylmalonic acid
Ethylmalonic acid can be found in blood cerebrospinal fluid (CSF) and urine as well as in human fibroblasts prostate and skeletal muscle tissues. Moreover ethylmalonic acid is found to be associated with anorexia nervosa and malonyl-CoA decarboxylase deficiency. Ethylmalonic acid is a non-carcinogenic potentially toxic compound.
-
Burosumab
Burosumab(KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
-
Loureirin D
Originated from blood, analgesic and anti-inflammatory.
